McIlrath & Eck’s Chemed CHE Stock Holding History

McIlrath & Eck’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21	Closed	-$10K	–	843
2022 Q2	$10K	Hold	21	–	–	﹤0.01%	506
2022 Q1	$11K	Hold	21	–	–	﹤0.01%	510
2021 Q4	$11K	Buy	+21	New	+$10.1K	﹤0.01%	519

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

McIlrath & Eck's CHE Position: Q3 2022 in Review

McIlrath & Eck sold out of Chemed (CHE) in Q3 2022, closing a stake of 21 shares — an estimated $10K sold.

McIlrath & Eck first reported a position in CHE in Q4 2021 and held it in 3 quarters. The position peaked at $11K in Q1 2022. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

McIlrath & Eck reported no remaining Chemed position as of Q3 2022 after selling out during the quarter.
McIlrath & Eck sold 21 Chemed shares in Q3 2022, an estimated $10K.
McIlrath & Eck first reported a position in Chemed in Q4 2021 and held it in 3 quarters.
McIlrath & Eck's Chemed position peaked at $11K in Q1 2022.
419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on McIlrath & Eck's 13F filing for Q3 2022, filed 18 Oct 2022.